Format

Send to

Choose Destination
World J Nucl Med. 2015 Jan-Apr;14(1):63-5. doi: 10.4103/1450-1147.150557.

Positron Emission Mammography Imaging with Low Activity Fluorodeoxyglucose and Novel Utilization in Core-needle Biopsy Sampling.

Author information

1
Department of Radiology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Tx 75390, USA.

Abstract

Positron emission mammography (PEM), a relatively novel breast imaging modality, provides certain advantages over magnetic resonance imaging, including the ability to image biopsy samples. However, the radiation activity associated with PEM has remained a concern in clinical practice. We present a case of an invasive ductal carcinoma that was adequately imaged with a much lower than the standard 185 to 370 MBq activity of (18)F-fluorodeoxyglucose. In addition, we demonstrate ultrasound-guided core-needle biopsy sample imaging with PEM to assess adequacy of sampling, a strategy that has previously only been documented with vacuum-assisted biopsy samples.

KEYWORDS:

Activity; biopsy; cancer; fluorodeoxyglucose; positron emission mammography

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center